|
Hypertrophy
Citations 381-390 of 489 total displayed.
|
Past content
(since Jan 1999):
|
- Editorials
Does Angiotensin-(1–7) Contribute to Cardiac Adaptation and Preservation of Endothelial Function in Heart Failure?
- Carlos M. Ferrario
Circulation 2002;105:1523-1525, doi:10.1161/01.CIR.0000013787.10609.DC
[Full text]
- Articles
Effects of Matrix Metalloproteinase Inhibition on
Ventricular Remodeling Due to Volume
Overload
- Amanda L. Chancey, Gregory L. Brower, J. Thomas Peterson, and Joseph S. Janicki
Circulation published April 1, 2002, doi:10.1161/01.CIR.0000014686.73212.DA
[Abstract]
- Brief Rapid Communications
Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
- B. Sachdev, T. Takenaka, H. Teraguchi, C. Tei, P. Lee, W.J. McKenna, and P.M. Elliott
Circulation 2002;105:1407-1411, doi:10.1161/01.CIR.0000012626.81324.38
[Abstract]
[Full text]
- Clinical Cardiology: New Frontiers
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part II: Causal Mechanisms and Treatment
- Michael R. Zile and Dirk L. Brutsaert
Circulation 2002;105:1503-1508, doi:10.1161/hc1202.105290
[Full text]
- Articles
Cardiovascular Influences of
 1b-Adrenergic Receptor Defect in
Mice
- Carmine Vecchione, Luigi Fratta, Damiano Rizzoni, Antonella Notte, Roberta Poulet, Enzo Porteri, Giacomo Frati, Daniele Guelfi, Valentina Trimarco, Michael J. Mulvany, Enrico Agabiti-Rosei, Bruno Trimarco, Susanna Cotecchia, and Giuseppe Lembo
Circulation published March 25, 2002, doi:10.1161/01.CIR.0000012750.08480.55
[Abstract]
- Basic Science Reports
Effects of Cariporide and Losartan on Hypertrophy, Calcium Transients, Contractility, and Gene Expression in Congestive Heart Failure
- Jan P. Loennechen, Ulrik Wisløff, Geir Falck, and Øyvind Ellingsen
Circulation 2002;105:1380-1386; published online before print as doi:10.1161/hc1102.105258
[Abstract]
[Full text]
- Clinical Cardiology: New Frontiers
New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part I: Diagnosis, Prognosis, and Measurements of Diastolic Function
- Michael R. Zile and Dirk L. Brutsaert
Circulation 2002;105:1387-1393, doi:10.1161/hc1102.105289
[Full text]
- Basic Science Reports
Peroxisome Proliferator-Activated Receptor  Plays a Critical Role in Inhibition of Cardiac Hypertrophy In Vitro and In Vivo
- Masayuki Asakawa, Hiroyuki Takano, Toshio Nagai, Hiroki Uozumi, Hiroshi Hasegawa, Naoto Kubota, Toshihiro Saito, Yoshiaki Masuda, Takashi Kadowaki, and Issei Komuro
Circulation 2002;105:1240-1246; published online before print as doi:10.1161/hc1002.105225
[Abstract]
[Full text]
- Clinical Investigations and Reports
Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study
- Kristian Wachtell, Jonathan N. Bella, Jens Rokkedal, Vittorio Palmieri, Vasilios Papademetriou, Björn Dahlöf, Tapio Aalto, Eva Gerdts, and Richard B. Devereux
Circulation 2002;105:1071-1076; published online before print as doi:10.1161/hc0902.104599
[Abstract]
[Full text]
- Clinical Investigations and Reports
Remodeling of Left Ventricular Hypertrophy in Elite Athletes After Long-Term Deconditioning
- Antonio Pelliccia, Barry J. Maron, Rosanna De Luca, Fernando M. Di Paolo, Antonio Spataro, and Franco Culasso
Circulation 2002;105:944-949; published online before print as doi:10.1161/hc0802.104534
[Abstract]
[Full text]
|
|
